Who
Alistair Milnes
Director
Company insider
Files Form 4 as: Director, Femasys; Chief Operating Officer, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 18
- Bought
- $0
- Sold
- $408K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Jan 2022
- Last trade
- 24 Jun 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 11 Aug 2026 | FEMY Femasysoption or derivative · Medical Devices | SEC FORM 4 Code A | —880 at $0.00 | filing |
| 24 Jun 2026filed 11 Aug 2026 | FEMY Femasysoption or derivative · Medical Devices | SEC FORM 4 Code A | —880 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $22K3,416 at $6.46 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $22K3,416 at $6.46 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $22K3,244 at $6.80 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $22K3,244 at $6.80 | filing |
| 3 Oct 2025filed 6 Oct 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $8,225978 at $8.41 | filing |
| 2 Oct 2025filed 6 Oct 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,6351,147 at $8.40 | filing |
| 3 Jul 2025filed 7 Jul 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,187966 at $7.44 | filing |
| 2 Jul 2025filed 7 Jul 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $8,1461,149 at $7.09 | filing |
| 25 Jun 2025filed 27 Jun 2025 | FEMY Femasysoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 3 Apr 2025filed 4 Apr 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,7641,038 at $7.48 | filing |
| 2 Apr 2025filed 4 Apr 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,0871,133 at $8.02 | filing |
| 3 Jan 2025filed 6 Jan 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $14K936 at $14.75 | filing |
| 2 Jan 2025filed 6 Jan 2025 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.